Gain Therapeutics inc (GANX) Annual Balance Sheets

Annual · GAAP · USD millions
Access GANX quarterly Balance Sheets →
Balance sheet patterns shown here provide context for understanding Gain Therapeutics inc's financial stability and long-term positioning.
Annual Report, GAAP in USD millions
ITEM
(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent20.84
Marketable Securities, Current SH0.00
Cash & Short-term Investments20.00
Other Current Assets0.18
Prepaid Expense And Other Assets Current1.22
Total Current Assets22.24
Equipment/Property/Plant Net0.07
Long-term investments0.00
Other Assets, Noncurrent0.51
Deferred Income Taxes And Other Tax Receivable Current0.18
Operating Lease Right Of Use Asset0.33
Restricted Cash Noncurrent0.04
Total Assets22.82
Liabilities
Accounts Payable, Current AC0.83
Long-term Debt, Current Maturities LO0.10
Other Liabilities, Current2.31
Taxes Payable, Current, Total0.00
Total Current Liabilities3.35
Long-term debt0.30
Total Long-term Debt0.30
Defined Benefit Pension Plan, Liabilities, Noncurrent PE0.39
Other liabilities, Noncurrent0.00
Operating Lease Liability Current0.12
Deferred Income Current-
Operating Lease Liability Noncurrent0.21
Total Liabilities4.25
Stockholders' Equity
Income Loss For Period-20.16
Common Stock Value0.00
Additional Paid In Capital Common Stock119.14
Retained Earnings / Accumulated Deficit-81.19
Other Equity0.78
Common Stockholder's Equity18.56
Total Stockholder's Equity18.56
Liabilities & Stockholder's Equity22.82
4 historic quarters locked

Sign in to unlock the full Gain Therapeutics inc balance sheet history.

About Gain Therapeutics Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001104659-26-035188

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License